RARE Stockholders Approve Third Amended 2023 Incentive Plan, Elect Class I Directors, Ratify Ernst & Young LLP as Auditor
Ultragenyx Pharmaceutical Inc. · PHARMACEUTICAL PREPARATIONS · Now $23.94
-7.2% in 1d after detection
Post-detection moves
1h
—
1d
-7.2%
3d
-2.0%
7d
-3.8%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS